Evidence map›Paper›PMID 33715181›Full record

ArticleThe Journal of dermatology2021

Teledermatology in times of COVID-19.

Pia-Charlotte Stadler, Sonja Senner, Surina Frey, Benjamin M Clanner-Engelshofen, Leonie H Frommherz, Lars E French, Markus Reinholz

Open access · hybridAbstract read
In one paragraph

Article in The Journal of dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Bridging the gap through telemedicine: Pilot study on the acceptance and use of teledermatology for urticaria.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025
    Article
  3. Article
  4. The Past, the Present and the Future of Teledermatology: A Narrative Review.Clinical, cosmetic and investigational dermatology · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Telemedicine Use by Oculoplastic Surgeons During the COVID-19 Pandemic.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2022
    Article
  11. Teledermatology in the time of COVID-19.International journal of clinical practice · 2021
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Pia-Charlotte StadlerDepartment of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.ORCID https://orcid.org/0000-0001-5892-4925
Sonja SennerDepartment of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.ORCID https://orcid.org/0000-0002-8617-935X
Surina FreyDepartment of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
Benjamin M Clanner-EngelshofenDepartment of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
Leonie H FrommherzDepartment of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
Lars E FrenchDepartment of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
Markus ReinholzDepartment of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
LMU Klinikum · DEUniversity of Miami · US

Funding

Blended DEAL: Projekt DEALWOA Institution: KLINIKUM DER UNIVERSITAET MUNCHEN
6 · The paper itself

Abstract

Remote consultations are likely to grow in importance in the following years, especially if the coronavirus disease 2019 (COVID-19) pandemic continues. Patients' opinions on teledermatology have already been analyzed, but a current analysis during the COVID-19 pandemic is lacking. The purpose of this survey was to investigate the satisfaction of patients who had received dermatological advice via telephone during the COVID-19 pandemic and to analyze their general opinion about eHealth as well as possible limitations for a broad implementation. Ninety-one patients managed in the dermatology department using telephone consultation during the COVID-19 pandemic were interviewed. An anonymous questionnaire, including the established quality of life questionnaire (Dermatology Life Quality Index [DLQI]), was used. It was found that men were more satisfied with telephone consultations than women (p = 0.029), educational level and age did not correlate with satisfaction (p = 0.186 and 388, respectively), and the longer the waiting time for a telephone consultation, the lower the satisfaction (p = 0.001). Grouped analysis of all participants showed that the majority (54.0% n = 38/71) were "very happy" with the telephone consultation. Higher disease burden (DLQI) was associated with lower satisfaction (p = 0.042). The main stated reasons for using telemedicine were shorter waiting times (51.6% n = 47/91) and no travel requirement (57.1% n = 47/91). Almost one-quarter (23.1% n = 21/89) of patients would use teledermatology in the future, 17.6% (n = 16/89) would not, and 57.1% (n = 51/89) would only use it in addition to a traditional consultation with personal contact. In conclusion, most patients in the study group still preferred traditional face-to-face medical consultations to telephone consultations, but also desired an add-on telemedical tool. Dermatological care using more modern telemedicine technologies than telephone conferencing is needed to better address patients' desires, especially in times of the COVID-19 pandemic.

Indexed as

COVID-19PandemicsFemaleHumansMaleQuality of LifeReferral and ConsultationSARS-CoV-2Telephonebarrierscoronavirus disease 2019 pandemiceHealthteledermatologytelemedicine

Identifiers

PMID33715181
PMCPMC8250059
OpenAlexW3138736509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.